Literature DB >> 15728922

Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection.

Nigel Bourne1, Rachael Stegall, Raquel Montano, Michael Meador, Lawrence R Stanberry, Gregg N Milligan.   

Abstract

Zinc salt solutions administered as topical microbicides provided significant protection against herpes simplex virus type 2 infection in a mouse vaginal challenge model. However, at the therapeutic concentration, the salt solutions caused sloughing of sheets of vaginal epithelial cells. These observations limit the utility of zinc salts as microbicides and suggest that the application of zinc solutions to mucosal surfaces has the potential to cause damage that might increase susceptibility to secondary infections at a later time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728922      PMCID: PMC549274          DOI: 10.1128/AAC.49.3.1181-1183.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Microbicides for preventing transmission of genital herpes.

Authors:  Larry Zeitlin; Kevin J Whaley
Journal:  Herpes       Date:  2002-04

2.  The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model.

Authors:  N Bourne; D I Bernstein; J Ireland; A J Sonderfan; A T Profy; L R Stanberry
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

Review 3.  Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus.

Authors:  Marla J Keller; Mary E Klotman; Betsy C Herold
Journal:  J Antimicrob Chemother       Date:  2003-04-14       Impact factor: 5.790

4.  The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.

Authors:  R N Fichorova; L D Tucker; D J Anderson
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

5.  Zinc salts inactivate clinical isolates of herpes simplex virus in vitro.

Authors:  M Arens; S Travis
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents.

Authors:  Gregg N Milligan; Kristen L Dudley; Nigel Bourne; Alisa Reece; Lawrence R Stanberry
Journal:  Sex Transm Dis       Date:  2002-10       Impact factor: 2.830

7.  A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.

Authors:  H R Godfrey; N J Godfrey; J C Godfrey; D Riley
Journal:  Altern Ther Health Med       Date:  2001 May-Jun       Impact factor: 1.305

Review 8.  Clinical development of microbicides for the prevention of HIV infection.

Authors:  Osmond J D'Cruz; Fatih M Uckun
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

9.  WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report.

Authors: 
Journal:  Reprod Health Matters       Date:  2002-11

10.  Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice.

Authors:  N Bourne; L J D Zaneveld; J A Ward; J P Ireland; L R Stanberry
Journal:  Clin Microbiol Infect       Date:  2003-08       Impact factor: 8.067

View more
  15 in total

1.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

2.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 3.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

4.  Estradiol improves genital herpes vaccine efficacy in mice.

Authors:  Jeffry W Pennock; Rachael Stegall; Brent Bell; Gracie Vargas; Massoud Motamedi; Gregg Milligan; Nigel Bourne
Journal:  Vaccine       Date:  2009-08-04       Impact factor: 3.641

5.  Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.

Authors:  Gita N Shankar; Carsten Alt
Journal:  J Antimicrob Chemother       Date:  2014-08-19       Impact factor: 5.790

6.  Zinc Lactate and Sapindin Act Synergistically with Lactocin 160 Against Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06-01       Impact factor: 4.609

7.  Optical coherence tomography for assessment of microbicide safety in a small animal model.

Authors:  Brent A Bell; Kathleen L Vincent; Nigel Bourne; Gracie Vargas; Massoud Motamedi
Journal:  J Biomed Opt       Date:  2013-04       Impact factor: 3.170

8.  A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.

Authors:  Jessica Kenney; Aixa Rodríguez; Larisa Kizima; Samantha Seidor; Radhika Menon; Ninochka Jean-Pierre; Pavel Pugach; Keith Levendosky; Nina Derby; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Gabriela Paglini; Thomas M Zydowsky; Melissa Robbiani; José A Fernández Romero
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

9.  Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.

Authors:  Karissa Lozenski; Robert Ownbey; Brian Wigdahl; Tina Kish-Catalone; Fred C Krebs
Journal:  BMC Pharmacol Toxicol       Date:  2012-10-01       Impact factor: 2.483

10.  Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.

Authors:  Joanna S Olsen; John T M DiMaio; Todd M Doran; Caitlin Brown; Bradley L Nilsson; Stephen Dewhurst
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.